bpc-157 fibromyalgia Peptide and Lyme Disease: Tissue Repair and Immune Support Benefits of BPC-157, The "Wolverine"
Description
Yudenfreundkravitz J
Clin Ther 33
Further investigations into the mechanism of action of TRZ at the spinal level are ongoing and further clinical studies could be useful to assess the effect of even lower doses of TRZ for treating neuropathic pain
Pick an anchor based on the goal: Skincare: 2 mg GHK-Cu daily, subcutaneous
Independent replication of some findings strengthens the evidence base
BPC-157 is not FDA-approved, so many physicians do not prescribe it
